To the editor regarding article "Coadministration of DPP-4 inhibitor and insulin therapy does not further reduce the risk of cardiovascular events compared with DPP-4 inhibitor therapy in diabetic foot patients: a nationwide population-based study"

被引：0
|
作者：
Mayer, Florian J. [1 ]
Pesau, Gerfried [2 ]
Schernthaner, Gerit H. [2 ]
机构：
[1] Med Univ Vienna, Dept Lab Med, Vienna, Austria
[2] Med Univ Vienna, Div Angiol, Dept Internal Med 2, Vienna, Austria
来源：
DIABETOLOGY & METABOLIC SYNDROME | 2018年 / 10卷
关键词：
RESISTANCE; DISEASE;
D O I：
10.1186/s13098-018-0394-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 33 条
  • [1] To the editor regarding article “Coadministration of DPP-4 inhibitor and insulin therapy does not further reduce the risk of cardiovascular events compared with DPP-4 inhibitor therapy in diabetic foot patients: a nationwide population-based study”
    Florian J. Mayer
    Gerfried Pesau
    Gerit H. Schernthaner
    Diabetology & Metabolic Syndrome, 10
  • [2] Coadministration of DPP-4 inhibitor and insulin therapy does not further reduce the risk of cardiovascular events compared with DPP-4 inhibitor therapy in diabetic foot patients: a nationwide population-based study
    Lin, Yi-Hsuan
    Huang, Yu-Yao
    Wu, Yi-Ling
    Lin, Cheng-Wei
    Chen, Pei-Chun
    Chang, Chee Jen
    Hsieh, Sheng-Hwu
    Sun, Jui-Hung
    Chen, Szu-Tah
    Lin, Chia-Hung
    DIABETOLOGY & METABOLIC SYNDROME, 2018, 10
  • [3] Coadministration of DPP-4 inhibitor and insulin therapy does not further reduce the risk of cardiovascular events compared with DPP-4 inhibitor therapy in diabetic foot patients: a nationwide population-based study
    Yi-Hsuan Lin
    Yu-Yao Huang
    Yi-Ling Wu
    Cheng-Wei Lin
    Pei-Chun Chen
    Chee Jen Chang
    Sheng-Hwu Hsieh
    Jui-Hung Sun
    Szu-Tah Chen
    Chia-Hung Lin
    Diabetology & Metabolic Syndrome, 10
  • [4] Obesity and Cardiovascular Risk: Effects of Dual Therapy Intensification with a DPP-4 Inhibitor Compared with Insulin
    Idris, Iskandar
    Mamza, Jil
    Mehta, Raj
    Donnelly, Richard
    DIABETES, 2015, 64 : A387 - A387
  • [5] Effect of a DPP-4 inhibitor on liver and Heart fat and cardiovascular risk in Type II diabetic patients
    Kosi, Lana
    Chmelik, Marek
    Trattnig, Siegfried
    Strametz-Juranek, Jeanette
    Kautzky-Willer, Alexandra
    WIENER KLINISCHE WOCHENSCHRIFT, 2011, 123 : S6 - S6
  • [6] AN OBSERVATIONAL STUDY ON THE EFFECT OF DPP-4 INHIBITOR THERAPY IN PATIENTS WITH POST TRANSPLANT DIABETES MELLITUS
    Thiruvengadam, Srivathsan
    Bennett, Kirsten
    Chakera, Aron
    TRANSPLANT INTERNATIONAL, 2017, 30 : 509 - 509
  • [7] AN OBSERVATIONAL STUDY OF INSULIN RESISTANCE IN PATIENTS WITH POST TRANSPLANT DIABETES MELLITUS ON DPP-4 INHIBITOR THERAPY AND OTHER AGENTS
    Thiruvengadam, S.
    Bennett, K.
    Chakera, A.
    NEPHROLOGY, 2017, 22 : 22 - 22
  • [8] Efficacy of Concomitant Therapy in Japanese Type 2 Diabetes Mellitus Patients With Insulin and Sitagliptin, a DPP-4 Inhibitor
    Nakagami, Tomoko
    Ide, Risa
    Iwasaki, Naoko
    Ogata, Makiko
    Oya, Junko
    Osawa, Mari
    Tanaka, Nobue
    Takaike, Hiroko
    Sato, Asako
    Miura, Junnosuke
    Uchigata, Yasuko
    DIABETES, 2013, 62 : A298 - A298
  • [9] DPP-4 INHIBITORS AND CARDIOVASCULAR EVENTS IN TYPE 2 DIABETIC PATIENTS WITH CHRONIC KIDNEY DISEASE - A NATIONWIDE COHORT STUDY
    Huang, T.
    Hsiao, F.
    Shen, L.
    VALUE IN HEALTH, 2016, 19 (07) : A812 - A812
  • [10] Effect of a DPP-4 Inhibitor on Heart and Liver Fat and cardiovascular Risk in female Type-2-Diabetic Patients
    Kosi, Lana
    Chmelik, Marek
    Kautzky-Willer, Alexandra
    WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 (17-18) : 548 - 549
1234